Adagene
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Adagene generated cash of -$28,454,839, which is more than the previous year. Cash used in financing activities reached the amount of -$5,366,946 last year. Net change in cash is therefore -$33,824,421.
Cash Flow
| 2018 | -14.26M | -29.50M | 51.05M |
|---|---|---|---|
| 2019 | -18.15M | 24.85M | 69.69M |
| 2020 | -28.52M | 7.07M | 4.43M |
| 2021 | -43.41M | -2.50M | 145.35M |
| 2022 | -48.61M | -686.04K | 17.82M |
| 2023 | -28.45M | -77.35K | -5.36M |
ADAG Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 143.75M | 174.39M | 75.15M | 92.53M | 16.05M | 8.73M |
Operating activities | ||||||
Net income | -18.94M | -79.97M | -73.17M | -42.39M | -16.43M | -15.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 1.20M | 1.44M | 1.12M | 858.40K | 816.68K | 909.00K |
Stock-based compensation expense | 7.27M | 10.52M | 18.67M | 10.12M | 611.71K | 0 |
| Deferred income tax benefit | 7.27M | 10.52M | 18.67M | 10.12M | 611.71K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 397.40K | 3M | -3M | 480K | -480K | 0 |
Inventories | 0 | 0 | 6.01M | 925.17K | -2.58M | 0 |
Accounts payable | -572.37K | 344.50K | 1.51M | 1.09M | 153.73K | 389.12K |
Cash generated by operating activities | -28.45M | -48.61M | -43.41M | -28.52M | -18.15M | -14.26M |
Investing activities | ||||||
Purchases Of Investments | -47M | 0 | 0 | -7.93K | -19M | -58M |
Investments In Property Plant And Equipment | -85.01K | -690.93K | -2.50M | -935.19K | -151.82K | -514.70K |
Acquisitions Net | 0 | 4.88K | 0 | 7.93K | 7.69K | 0 |
Cash generated by investing activities | -77.35K | -686.04K | -2.50M | 7.07M | 24.85M | -29.50M |
Financing activities | ||||||
Common Stock Issued | 5.49K | 0 | 149.79M | -580.60K | 69.45M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -3.97M | -2.36M | 0 | 0 | 0 |
Repayments of term debt | -5.37M | 21.47M | -5.08M | -1.06M | 234.68K | -1.36M |
Cash used in financing activities | -5.36M | 17.82M | 145.35M | 4.43M | 69.69M | 51.05M |
Net Change In Cash | -33.82M | -30.63M | 99.24M | -17.38M | 76.47M | 7.32M |
Cash at end of period | 109.93M | 143.75M | 174.39M | 75.15M | 92.53M | 16.05M |
| Data source | Data source | Data source | Data source |